Private equity activity in gastroenterology is slowing in frequency, even as deal sizes and consolidation momentum grow. This shift is redefining the field — and what independent GI groups and ASCs ...

A dramatic rise in colorectal cancer among adults under 50 — especially those ages 45–49 — is driving a major shift across gastroenterology and ASCs. Screening guidelines dropped to age 45 in 2021, ...